• Drug Candidate GLR2007 Granted FDA Orphan Drug Designation americanpharmaceuticalreview
    September 18, 2020
    Gan & Lee Pharmaceuticals announced the U.S Food and Drug Administration (FDA) has granted Orphan Drug Designation for GLR2007, for the treatment of malignant glioma. GLR2007 is a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor that ...
PharmaSources Customer Service